Puma Biotechnology
PBYI
PBYI
111 hedge funds and large institutions have $89.7M invested in Puma Biotechnology in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 46 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 100 → 111 (+11)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.76% less ownership
Funds ownership: 60.63% → 59.88% (-0.76%)
Holders
111
Holding in Top 10
1
Calls
$137K
Puts
$16K
Top Buyers
| 1 | +$660K | |
| 2 | +$522K | |
| 3 | +$504K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$465K |
| 5 |
Two Sigma Investments
New York
|
+$402K |
Top Sellers
| 1 | -$7.81M | |
| 2 | -$3.01M | |
| 3 | -$906K | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$826K |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$638K |